相关实验视频

Updated: Jun 9, 2025

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

在先天性 ichthyosis 的生物药物:他们是有效的吗?

Juliette Mazereeuw-Hautier¹, Céline Granier Tournier¹, Angela Hernandez-Martin

¹Department of Dermatology, Reference Centre for Rare Skin Diseases, Toulouse University Hospital, Paul Sabatier University, Toulouse, France.

The British journal of dermatology

|October 29, 2024

概括

生物药物显示出治疗严重先天性 ichthyosis 的潜力,近一半的患者反应良好. 针对IL-17,IL-12/23或IL-4R的特定治疗方法在Netherton综合征和先天性 ichthyosiform erythroderma等子集中最有效.

科学领域:

皮肤病学皮肤病学
遗传学遗传学是一个
免疫学免疫学免疫学

背景情况:

遗传性 Ichthyosis 是一种严重的遗传性皮肤疾病,影响生活质量.
目前的治疗方法对红疹和提供有限的缓解.
细胞因子的改变表明生物药物是一种潜在的治疗途径.

研究的目的:

评估先天性 ichthyoses 的患者在生物疗法的现实世界的有效性.
为了确定特定的先天性 ichthyosis 亚型,可能从生物治疗中受益.

主要方法:

追溯性,国际,多中心研究,对98名先天性 ichthyoses 患者进行了生物治疗,治疗时间≥3个月.
使用研究人员全球变化评估 (IGA-C) 尺度对治疗疗效的评估.
并行全面的文献审查,以评估报告的结果和潜在的偏见.

主要成果:

46%的患者对生物药物有反应,18%的患者有良好的反应,主要是那些有红皮形式的患者.
最常使用的药物是干白素 (IL) -17 ,IL-12/23和IL-4受体 (IL-4R) 抑制剂.
IL-12/23和IL-4R抑制剂在尼瑟顿综合症 (NS) 和先天性胆形红皮病 (CIE) 中表现出特别的疗效.

结论:

特定的先天性 ichthyosis 亚组表明对生物药物的潜在反应.
这些发现可以为未来的先天性 ichthyosis 的生物疗法临床试验的设计提供信息.
文献审查表明,在以前发表的生物治疗结果中,潜在的记者偏见.

更多相关视频

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.